Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Enzalutamide in Combination With Indomethacin in Castration-Resistant Prostate Cancer (CRPC)

NCT02935205 is registered in ClinicalTrials.gov with Mamta Parikh as lead sponsor.

NCT NCT02935205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02935205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Enzalutamide in Combination With Indomethacin in Castration-Resistant Prostate Cancer (CRPC)
Lead sponsor
Mamta Parikh
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 17, 2017
Completion date
December 31, 2024
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate carcinoma, recurrent prostate carcinoma, stage iv prostate cancer